Alterity Therapeutics Limited

ATHE

—

Last 30 days -7.30% Jun 22 → Jul 28

Open

—

High

—

Low

—

Volume

—

Avg Vol

—

Mkt Cap

$85M

P/E (TTM)

—

Beta

—

52w High

—

52w Low

—

Div Yield

—

Shares Out

—

Recent Press Releases & News last 60 days · 4 items

Jul 21 · 11:25 PR GlobeNewswire

Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026

Jul 7 · 11:45 MT Newswires

Alterity Therapeutics Says FDA Backs Phase 3 Design for Multiple System Atrophy Therapy

Jul 7 · 11:05 PR GlobeNewswire

Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy

▸ Show all 4 press releases & news Free account →

Overview

52-week range

—

Avg surprise (last 0)

—

Avg reaction (last 0)

—

Earnings trends

Upcoming

Date	Fiscal	Time	EPS Est	LY EPS	YoY %Δ
Thu Aug 27, 2026	Jun/2026	OTHER	—	—

Implied volatility — last 90 days

No IV snapshots yet for ATHE.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

View on Nasdaq ↗